200
Views
2
CrossRef citations to date
0
Altmetric
Review

Functional abdominal pain disorders and asthma: two disorders, but similar pathophysiology?

, , &
Pages 9-24 | Received 19 Apr 2020, Accepted 07 Sep 2020, Published online: 21 Sep 2020

References

  • Hyams JS, Di Lorenzo C, Saps M, et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology. 2016;150:1456–1468.e2.
  • Korterink JJ, Diederen K, Benninga MA, et al. Epidemiology of pediatric functional abdominal pain disorders: a meta-analysis. Zhang L, editor. PLoS One. 2015;10:e0126982.
  • Chang F-Y, Chen P-H, Wu T-C, et al. Prevalence of functional gastrointestinal disorders in Taiwan: questionnaire-based survey for adults based on the Rome III criteria. Asia Pac J Clin Nutr. 2012;21:594–600.
  • Devanarayana NM, Rajindrajith S, Benninga MA. Quality of life and health care consultation in 13 to 18 year olds with abdominal pain predominant functional gastrointestinal diseases. BMC Gastroenterol. 2014;14:150.
  • Park R, Mikami S, LeClair J, et al. Inpatient burden of childhood functional GI disorders in the USA: an analysis of national trends in the USA from 1997 to 2009. Neurogastroenterol Motil. 2015;27:684–692.
  • Ranasinghe N, Devanarayana NM, Rajindrajith S, et al. Functional gastrointestinal diseases and psychological maladjustment, personality traits and quality of life. BMC Gastroenterol. 2018;18:33.
  • Aziz I, Palsson OS, Törnblom H, et al. The prevalence and impact of overlapping Rome IV-diagnosed functional gastrointestinal disorders on somatization, quality of life, and healthcare utilization: a cross-sectional general population study in three countries. Am J Gastroenterol. 2018;113:86–96.
  • Chang L. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther. 2004;20:31–39.
  • Aziz I, Palsson OS, Törnblom H, et al. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study. Lancet Gastroenterol Hepatol. 2018;3:252–262.
  • Horak F, Doberer D, Eber E, et al. Diagnosis and management of asthma - statement on the 2015 GINA guidelines. Wien Klin Wochenschr. 2016;128:541–554.
  • To T, Stanojevic S, Moores G, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012;12:204.
  • Pearce N, Aït-Khaled N, Beasley R, et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax. 2007;62:758–766.
  • Gibson PG, Henry RL, Vimpani GV, et al. Asthma knowledge, attitudes, and quality of life in adolescents. Arch Dis Child. 1995;73:321–326.
  • Sundberg R, Palmqvist M, Tunsäter A, et al. Health-related quality of life in young adults with asthma. Respir Med. 2009;103:1580–1585.
  • Wang K-Y, Wu C-P, Tang -Y-Y, et al. Health-related quality of life in Taiwanese patients with bronchial asthma. J Formos Med Assoc. 2004;103:205–211.
  • Ali Z, Dirks CG, Ulrik C. Long-term mortality among adults with asthma: a 25-year follow-up of 1,075 outpatients with asthma. Chest J. 2013;143:1649–1655.
  • White AM, Stevens WH, Upton AR, et al. Airway responsiveness to inhaled methacholine in patients with irritable bowel syndrome. Gastroenterology. 1991;100:68–74.
  • Kennedy TM, Jones RH, Hungin AP, et al. Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut. 1998;43:770–774.
  • Roussos A, Koursarakos P, Patsopoulos D, et al. Increased prevalence of irritable bowel syndrome in patients with bronchial asthma. Respir Med. 2003;97:75–79.
  • Ekici A, Guliter S, Ekici M, et al. Irritable bowel syndrome in young and elderly patients with stable asthma. Dig Liver Dis. 2005;37:773–778.
  • Ozol D, Uz E, Bozalan R, et al. Relationship between asthma and irritable bowel syndrome: role of food allergy. J Asthma. 2006;43:773–775.
  • Powell N, Huntley B, Beech T, et al. Increased prevalence of gastrointestinal symptoms in patients with allergic disease. Postgrad Med J. 2007;83:182–186.
  • Yilmaz A, Cumurcu BE, Tasliyurt T, et al. Role of psychiatric disorders and irritable bowel syndrome in asthma patients. Clinics. 2011;66:591–597.
  • Panicker R, Arifhodzic N, Al Ahmad M, et al. Association and symptom characteristics of irritable bowel syndrome among bronchial asthma patients in Kuwait. Ann Thorac Med. 2010;5:37–42.
  • Huerta C, Rodríguez LAG, Wallander MA, et al. Risk of irritable bowel syndrome among asthma patients. Pharmacoepidemiol Drug Saf. 2002;11:31–35.
  • Cole JA, Rothman KJ, Cabral HJ, et al. Incidence of IBS in a cohort of people with asthma. Dig Dis Sci. 2007;52:329–335.
  • Shen TC, Lin CL, Wei CC, et al. Bidirectional association between asthma and irritable bowel syndrome: two population-based retrospective Cohort studies. PLoS One. 2016;11:e0153911.
  • Yazar A, Atis S, Konca K, et al. Respiratory symptoms and pulmonary functional changes in patients with irritable bowel syndrome. Am J Gastroenterol. 2001;96:1511–1516.
  • Jones MP, Walker MM, Ford AC, et al. The overlap of atopy and functional gastrointestinal disorders among 23 471 patients in primary care. Aliment Pharmacol Ther. 2014;40:382–391.
  • Amra B, Hoseini-Asl MK, Rahmani AR, et al. Correlation between asthma and irritable bowel syndrome in a general population in Iran in 2003. Respir Med. 2006;100:110–114.
  • Tobin MC, Moparty B, Farhadi A, et al. Atopic irritable bowel syndrome: a novel subgroup of irritable bowel syndrome with allergic manifestations. Ann Allergy Asthma Immunol. 2008;100:49–53.
  • Kumari MV, Devanarayana NM, Amarasiri L, et al. Association between functional abdominal pain disorders and asthma in adolescents: a cross-sectional study. World J Clin Cases. 2018;6:944–951.
  • Koloski N, Jones M, Walker MM, et al. Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress. Aliment Pharmacol Ther. 2019;49:546–555.
  • Amra B, Emami MH, Drooshi B, et al. Airway resistance in irritable bowel syndrome as measured by impulse oscillometry. Indian J Gastroenterol. 2006;25:185–187.
  • Cardoso WV, Lü J. Regulation of early lung morphogenesis: questions, facts and controversies. Development. 2006;133:1611–1624.
  • Chinoy MR. Lung growth and development. Front Biosci. 2003;8:392–415.
  • Tollet J, Everett AW, Sparrow MP. Migration of neural crest cells into and within the developing lung. Int J Dev Neurosci. 2002;19:707.
  • Natarajan D, Marcos-Gutierrez C, Pachnis V, et al. Requirement of signalling by receptor tyrosine kinase RET for the directed migration of enteric nervous system progenitor cells during mammalian embryogenesis. Development. 2002;129:5151–5160.
  • Locke GR, Zinsmeister AR, Talley NJ, et al. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc. 2000;75:907–912.
  • Levy RL, Jones KR, Whitehead WE, et al. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology. 2001;121:799–804.
  • Buonavolontà R, Coccorullo P, Turco R, et al. Familial aggregation in children affected by functional gastrointestinal disorders. J Pediatr Gastroenterol Nutr. 2010;50:1.
  • Lewis ML, Palsson OS, Whitehead WE, et al. Prevalence of functional gastrointestinal disorders in children and adolescents. J Pediatr. 2016;177:39–43.e3.
  • Moffatt MF, Gut IG, Demenais F, et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med. 2010;363:1211–1221.
  • Zhu G, Whyte MK, Vestbo J, et al. Interleukin 18 receptor 1 gene polymorphisms are associated with asthma. Eur J Hum Genet. 2008;16:1083–1090.
  • Sato N, Suzuki N, Sasaki A, et al. Corticotropin-releasing hormone receptor 1 gene variants in Irritable bowel syndrome. PLoS One. 2012;7:e42450.
  • Sasaki A, Sato N, Suzuki N, et al. Associations between single-nucleotide polymorphisms in corticotropin-releasing hormone-related genes and Irritable bowel syndrome. PLoS One. 2016;11:e0149322.
  • Vaiopoulou A, Karamanolis G, Psaltopoulou T, et al. Molecular basis of the irritable bowel syndrome. World J Gastroenterol. 2014;20:376–383.
  • Kavalar MS, Balantic M, Silar M, et al. Association of ORMDL3, STAT6 and TBXA2R gene polymorphisms with asthma. Int J Immunogenet. 2012;39:20–25.
  • Pykäläinen M, Kinos R, Valkonen S, et al. Association analysis of common variants of STAT6, GATA3, and STAT4 to asthma and high serum IgE phenotypes. J Allergy Clin Immunol. 2005;115:80–87.
  • Himes BE, Hunninghake GM, Baurley JW, et al. Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. Am J Hum Genet. 2009;84:581–593.
  • London SJ, Gao W, Gharib SA, et al. ADAM19 and HTR4 variants and pulmonary function cohorts for heart and aging research in genomic epidemiology (charge) consortium targeted sequencing study. Circ Cardiovasc Genet. 2014;7:350–358.
  • Saito YA, Mitra N, Mayer EA. Genetic approaches to functional gastrointestinal disorders. Gastroenterology. 2010;138:1276–1285.
  • Swan C, Duroudier NP, Campbell E, et al. Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα. Gut. 2013;62:985–994.
  • Ek WE, Reznichenko A, Ripke S, et al. Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts. Gut. 2015;64:1774–1782.
  • Zucchelli M, Camilleri M, Nixon Andreasson A, et al. Association of TNFSF15 polymorphism with irritable bowel syndrome. Gut. 2011;60:1671–1677.
  • Mayer EA, Labus JS, Tillisch K, et al. Towards a systems view of IBS. Nat Rev Gastroenterol Hepatol. 2015;12:592–605.
  • McGowan PO, Sasaki A, D’Alessio AC, et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci. 2009;12:342–348.
  • Hemminki K, Li X, Sundquist K, et al. Familial risks for asthma among twins and other siblings based on hospitalizations in Sweden. Clin Exp Allergy. 2007;37:1320–1325.
  • Thomsen SF, van der Sluis S, Kyvik KO, et al. A study of asthma severity in adult twins. Clin Respir J. 2012;6:228–237.
  • Thomsen SF, Duffy DL, Kyvik KO, et al. Genetic influence on the age at onset of asthma: a twin study. J Allergy Clin Immunol. 2010;126:626–630.
  • Thomsen SF, van der Sluis S, Kyvik KO, et al. Estimates of asthma heritability in a large twin sample. Clin Exp Allergy. 2010;40:1054–1061.
  • Kumar RK, Hitchins MP, Foster PS. Epigenetic changes in childhood asthma. Dis Model Mech. 2009;2:549–553.
  • Kabesch M, Michel S, Tost J. Epigenetic mechanisms and the relationship to childhood asthma. Eur Respir J. 2010;36:950–961.
  • Thomsen SF. Genetics of asthma: an introduction for the clinician. Eur Clin Respir J. 2015;2:24643.
  • Brady RE, Glovsky MM, Opelz G, et al. The association of an HLA “asthma-associated” haplotype and immediate hypersensitivity in familial asthma. Int J Immunogenet. 1981;8:509–517.
  • Kontakioti E, Domvri K, Papakosta D, et al. HLA and asthma phenotypes/endotypes: a review. Hum Immunol. 2014;75:930–939.
  • Vazquez-Roque MI, Camilleri M, Smyrk T, et al. Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea. Am J Physiol Gastrointest Liver Physiol. 2012;303:G1262–9.
  • Adeniyi OF, Adenike Lesi O, Olatona FA, et al. Irritable bowel syndrome in adolescents in Lagos. Pan Afr Med J. 2017;28:93.
  • Rajindrajith S, Devanarayana NM. Subtypes and symptomatology of irritable bowel syndrome in children and adolescents: a school-based survey using Rome III criteria. J Neurogastroenterol Motil. 2012;18:298–304.
  • Heitkemper MM, Chang L. Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome? Gend Med. 2009;6(Suppl 2):152–167.
  • Chumpitazi BP, Weidler EM, Czyzewski DI, et al. Childhood irritable bowel syndrome characteristics are related to both sex and pubertal development. J Pediatr. 2017;180:141–147.e1.
  • Koper I, Hufnagl K, Ehmann R. Gender aspects and influence of hormones on bronchial asthma - secondary publication and update. World Allergy Organ J. 2017;10:46.
  • Tollefsen E, Langhammer A, Romundstad P, et al. Female gender is associated with higher incidence and more stable respiratory symptoms during adolescence. Respir Med. 2007;101:896–902.
  • Postma DS. Gender differences in asthma development and progression. Gend Med. 2007;4(SupplB):S133–46.
  • Vink NM, Postma DS, Schouten JP, et al. Gender differences in asthma development and remission during transition through puberty: the TRacking Adolescents’ Individual Lives Survey (TRAILS) study. J Allergy Clin Immunol. 2010;126:498–504.e1–6.
  • Kynyk JA, Mastronarde JG, McCallister JW. Asthma, the sex difference. Curr Opin Pulm Med. 2011;17:6–11.
  • Zhu X, Chen W, Zhu X, et al. A cross-sectional study of risk factors for irritable bowel syndrome in children 8–13 years of age in Suzhou, China. Gastroenterol Res Pract. 2014;2014:198461.
  • Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. N Engl J Med. 1995;332:133–138.
  • Mommers M, Gielkens-Sijstermans C, Swaen GMH, et al. Trends in the prevalence of respiratory symptoms and treatment in Dutch children over a 12 year period: results of the fourth consecutive survey. Thorax. 2005;60:97–99.
  • Gerritsen J. Follow-up studies of asthma from childhood to adulthood. Paediatr Respir Rev. 2002;3:184–192.
  • Devanarayana NM, Mettananda S, Liyanarachchi C, et al. Abdominal pain–predominant functional gastrointestinal diseases in children and adolescents: prevalence, symptomatology, and association with emotional stress. J Pediatr Gastroenterol Nutr. 2011;53:659–665.
  • Devanarayana NM, Rajindrajith S, Perera MS, et al. Association between functional gastrointestinal diseases and exposure to abuse in teenagers. J Trop Pediatr. 2014;60:386–392.
  • Boey CCM, Goh KL. Stressful life events and recurrent abdominal pain in children in a rural district in Malaysia. Eur J Gastroenterol Hepatol. 2001;13:401–404.
  • Boey CCM, Goh KL. The significance of life-events as contributing factors in childhood recurrent abdominal pain in an urban community in Malaysia. J Psychosom Res. 2001;51:559–562.
  • Huang RC, Palmer LJ, Forbes DA. Prevalence and pattern of childhood abdominal pain in an Australian general practice. J Paediatr Child Health. 2000;36:349–353.
  • Mayer EA, Bradesi S, Chang L, et al. Functional GI disorders: from animal models to drug development. Gut. 2008;57:384–404.
  • Song SW, Park SJ, Kim SH, et al. Relationship between irritable bowel syndrome, worry and stress in adolescent girls. J Korean Med Sci. 2012;27:1398–1404.
  • Dong L, Dingguo L, Xiaoxing X, et al. An epidemiologic study of irritable bowel syndrome in adolescents and children in China: a school-based study. Pediatrics. 2005;116:e393–6.
  • Sandberg S, Paton JY, Ahola S, et al. The role of acute and chronic stress in asthma attacks in children. Lancet. 2000;356:982–987.
  • Oren E, Gerald L, Stern DA, et al. Self-reported stressful life events during adolescence and subsequent asthma: a longitudinal study. J Allergy Clin Immunol Pract. 2017;5:427–434.e2.
  • Loerbroks A, Apfelbacher CJ, Thayer JF, et al. Neuroticism, extraversion, stressful life events and asthma: a cohort study of middle-aged adults. Allergy. 2009;64:1444–1450.
  • Kilpeläinen M, Koskenvuo M, Helenius H, et al. Stressful life events promote the manifestation of asthma and atopic diseases. Clin Exp Allergy. 2002;32:256–263.
  • Razvodovsky YE. Psychosocial distress as a risk factor of asthma mortality. Psychiatr Danub. 2010;22:167–172.
  • Shankar M, Fagnano M, Blaakman SW, et al. Depressive symptoms among urban adolescents with asthma: a focus for providers. Acad Pediatr. 2018;19:608–614.
  • Oh H, Stickley A, Singh F, et al. Self-reported asthma diagnosis and mental health: findings from the collaborative psychiatric epidemiology surveys. Psychiatry Res. 2019;271:721–725.
  • Joachim RA, Quarcoo D, Arck PC, et al. Stress enhances airway reactivity and airway inflammation in an animal model of allergic bronchial asthma. Psychosom Med. 2003;65:811–815.
  • Coogan PF, Wise LA, O’Connor GT, et al. Abuse during childhood and adolescence and risk of adult-onset asthma in African American women. J Allergy Clin Immunol. 2013;131:1058–1063.
  • Devanarayana NM, Rajindrajith S. Irritable bowel syndrome in children: current knowledge, challenges and opportunities. World J Gastroenterol. 2018;24:2211–2235.
  • Rajindrajith S, Zeevenhooven J, Devanarayana NM, et al. Functional abdominal pain disorders in children. Expert Rev Gastroenterol Hepatol. 2018;12:369–390.
  • Jalusic-Gluncic T. What happens with airway resistance (RAW) in asthma and COPD exacerbation. Med Arch. 2011;65:270–273.
  • Kraft M, Djukanovic R, Wilson S, et al. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med. 1996;154:1505–1510.
  • Loxham M, Davies DE, Blume C. Epithelial function and dysfunction in asthma. Clin Exp Allergy. 2014;44:1299–1313.
  • Hamid Q, Tulic M. Immunobiology of asthma. Annu Rev Physiol. 2009;71:489–507.
  • Bradding P, Walls AF, Holgate ST. The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol. 2006;117:1277–1284.
  • Holgate S. Mediator and cytokine mechanisms in asthma. Thorax. 1993;48:103–109.
  • Korterink JJ, Devanarayana NM, Rajindrajith S, et al. Childhood functional abdominal pain: mechanisms and management. Nat Rev Gastroenterol Hepatol. 2015;12:159–171.
  • Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology. 2016;150:1262–1279.e2.
  • Borish L, Steinke JW. Interleukin-33 in asthma: how big of a role does it play? Curr Allergy Asthma Rep. 2011;11:7–11.
  • Bochner BS, Gleich GJ. What targeting eosinophils has taught us about their role in diseases. J Allergy Clin Immunol. 2010;126:16–25;quiz 26–7.
  • Cho SH, Anderson AJ, Oh CK. Importance of mast cells in the pathophysiology of asthma. Clin Rev Allergy Immunol. 2002;22:161–174.
  • Lazaar AL, Plotnick MI, Kucich U, et al. Mast cell chymase modifies cell-matrix interactions and inhibits mitogen-induced proliferation of human airway smooth muscle cells. J Immunol. 2002;169:1014–1020.
  • Keohane J, Quigley EMM. Functional dyspepsia: the role of visceral hypersensitivity in its pathogenesis. World J Gastroenterol. 2006;12:2672–2676.
  • Di Lorenzo C, Youssef NN, Sigurdsson L, et al. Visceral hyperalgesia in children with functional abdominal pain. J Pediatr. 2001;139:838–843.
  • Faure C, Giguere L. Functional gastrointestinal disorders and visceral hypersensitivity in children and adolescents suffering from Crohn’s disease. Inflamm Bowel Dis. 2008;14:1567–1574.
  • Halac U, Noble A, Faure C. Rectal sensory threshold for pain is a diagnostic marker of irritable bowel syndrome and functional abdominal pain in children. J Pediatr. 2010;156:60–65.
  • Priftis KN, Mermiri D, Papadopoulou A, et al. Asthma symptoms and bronchial reactivity in school children sensitized to food allergens in infancy. J Asthma. 2008;45:590–595.
  • Gosens R, Grainge C. Bronchoconstriction and airway biology. Chest. 2015;147:798–803.
  • Chin LYM, Bossé Y, Jiao Y, et al. Human airway smooth muscle is structurally and mechanically similar to that of other species. Eur Respir J. 2010;36:170–177.
  • Wallace AS, Burns AJ. Development of the enteric nervous system, smooth muscle and interstitial cells of Cajal in the human gastrointestinal tract. Cell Tissue Res. 2005;319:367–382.
  • Devanarayana NM, Rajindrajith S, Bandara C, et al. Ultrasonographic assessment of liquid gastric emptying and antral motility according to the subtypes of irritable bowel syndrome in children. J Pediatr Gastroenterol Nutr. 2013;56:443–448.
  • Devanarayana NM, Rajindrajith S, Perera MS, et al. Gastric emptying and antral motility parameters in children with functional dyspepsia: association with symptom severity. J Gastroenterol Hepatol. 2013;28:1161–1166.
  • Devanarayana NM, Rajindrajith S, Rathnamalala N, et al. Delayed gastric emptying rates and impaired antral motility in children fulfilling Rome III criteria for functional abdominal pain. Neurogastroenterol Motil. 2012;24:420–425.
  • Friesen CA, Lin Z, Hyman PE, et al. Electrogastrography in pediatric functional dyspepsia: relationship to gastric emptying and symptom severity. J Pediatr Gastroenterol Nutr. 2006;42:265–269.
  • Chen JD, Lin X, Zhang M, et al. Gastric myoelectrical activity in healthy children and children with functional dyspepsia. Dig Dis Sci. 1998;43:2384–2391.
  • Fixman ED, Stewart A, Martin JG. Basic mechanisms of development of airway structural changes in asthma. Eur Respir J. 2006;29:379–389.
  • James AL, Elliot JG, Jones RL, et al. Airway smooth muscle hypertrophy and hyperplasia in asthma. Am J Respir Crit Care Med. 2012;185:1058–1064.
  • Bai TR, Cooper J, Koelmeyer T, et al. The effect of age and duration of disease on airway structure in fatal asthma. Am J Respir Crit Care Med. 2000;162:663–669.
  • Amarasiri WADL, Pathmeswaran A, de Silva AP, et al. Gastric motility following ingestion of a solid meal in a cohort of adult asthmatics. J Neurogastroenterol Motil. 2013;19:355–365.
  • Terruzzi V, Magatti F, Quadri G, et al. Bladder dysfunction and irritable bowel syndrome. Am J Gastroenterol. 1992;87:1231–1232.
  • Whorwell PJ, Lupton EW, Erduran D, et al. Bladder smooth muscle dysfunction in patients with irritable bowel syndrome. Gut. 1986;27:1014–1017.
  • Walker EA, Katon WJ, Roy-Byrne PP, et al. Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease. Am J Psychiatry. 1993;150:1502–1506.
  • Veale D, Kavanagh G, Fielding JF, et al. Primary fibromyalgia and the irritable bowel syndrome: different expressions of a common pathogenetic process. Br J Rheumatol. 1991;30:220–222.
  • Bisaccioni C, Aun MV, Cajuela E, et al. Comorbidities in severe asthma: frequency of rhinitis, nasal polyposis, gastroesophageal reflux disease, vocal cord dysfunction and bronchiectasis. Clinics. 2009;64:769–773.
  • Caffarelli C, Deriu FM, Terzi V, et al. Gastrointestinal symptoms in patients with asthma. Arch Dis Child. 2000;82:131–135.
  • Hyland ME, Lanario JW, Wei Y, et al. Evidence for similarity in symptoms and mechanism: the extra-pulmonary symptoms of severe asthma and the polysymptomatic presentation of fibromyalgia. Immun Inflamm Dis. 2019;7:239–249.
  • Smart HL, Atkinson M. Abnormal vagal function in irritable bowel syndrome. Lancet. 1987;2:475–478.
  • Holgate ST. Pathogenesis of Asthma. Clin Exp Allergy. 2008;38:872–897.
  • Andersson C, Tufvesson E, Diamant Z, et al. Revisiting the role of the mast cell in asthma. Curr Opin Pulm Med. 2016;22:10–17.
  • Hirota N, Martin JG. Mechanisms of airway remodeling. Chest. 2013;144:1026–1032.
  • Robinson D, Humbert M, Buhl R, et al. Revisiting type 2-high and type 2-low airway inflammation in asthma: current knowledge and therapeutic implications. Clin Exp Allergy. 2017;47:161–175.
  • Xiao C, Puddicombe SM, Field S, et al. Defective epithelial barrier function in asthma. J Allergy Clin Immunol. 2011;128:549–556.e12.
  • Georas SN, Rezaee F. Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation. J Allergy Clin Immunol. 2014;134:509–520.
  • Ford AC, Talley NJ. Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review. J Gastroenterol. 2011;46:421–431.
  • Vanheel H, Vicario M, Vanuytsel T, et al. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut. 2014;63:262–271.
  • Walker MM, Warwick A, Ung C, et al. The role of eosinophils and mast cells in intestinal functional disease. Curr Gastroenterol Rep. 2011;13:323–330.
  • Wang X, Li X, Ge W, et al. Quantitative evaluation of duodenal eosinophils and mast cells in adult patients with functional dyspepsia. Ann Diagn Pathol. 2015;19:50–56.
  • Walker MM, Talley NJ, Prabhakar M, et al. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther. 2009;29:765–773.
  • Ohman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol. 2010;7:163–173.
  • Marshall JK, Thabane M, Garg AX, et al. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Aliment Pharmacol Ther. 2004;20:1317–1322.
  • Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol. 2003;98:1578–1583.
  • Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut. 1999;44:400–406.
  • de Waal Malefyt R, Abrams J, Bennett B, et al. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991;174:1209–1220.
  • De Silva AP, Nandasiri SD, Hewavisenthi J, et al. Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting. Scand J Gastroenterol. 2012;47:619–624.
  • Liebregts T, Adam B, Bredack C, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007;132:913–920.
  • Walker MM, Talley NJ. Functional gastrointestinal disorders and the potential role of eosinophils. Gastroenterol Clin North Am. 2008;37:383–395, vi.
  • Barbara G, Wang B, Stanghellini V, et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology. 2007;132:26–37.
  • Barbara G, Feinle-Bisset C, Ghoshal UC, et al. The intestinal microenvironment and functional gastrointestinal disorders. Gastroenterology. 2016;150:1305–1318.e8.
  • Bertiaux-Vandaële N, Youmba SB, Belmonte L, et al. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype. Am J Gastroenterol. 2011;106:2165–2173.
  • Martínez C, Lobo B, Pigrau M, et al. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Gut. 2013;62:1160–1168.
  • Coëffier M, Gloro R, Boukhettala N, et al. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome. Am J Gastroenterol. 2010;105:1181–1188.
  • Söderholm JD, Perdue MH. Stress and gastrointestinal tract. II. Stress and intestinal barrier function. Am J Physiol Gastrointest Liver Physiol. 2001;280:G7–G13.
  • Nakade Y, Fukuda H, Iwa M, et al. Restraint stress stimulates colonic motility via central corticotropin-releasing factor and peripheral 5-HT3 receptors in conscious rats. Am J Physiol Gastrointest Liver Physiol. 2007;292:G1037–44.
  • Konturek SJ, Brzozowski T, Konturek PC, et al. Day/night differences in stress-induced gastric lesions in rats with an intact pineal gland or after pinealectomy. J Pineal Res. 2008;44:408–415.
  • Naliboff BD, Derbyshire SW, Munakata J, et al. Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med. 2001;63:365–375.
  • Verne GN, Himes NC, Robinson ME, et al. Central representation of visceral and cutaneous hypersensitivity in the irritable bowel syndrome. Pain. 2003;103:99–110.
  • Karantanos T, Markoutsaki T, Gazouli M, et al. Current insights in to the pathophysiology of irritable bowel syndrome. Gut Pathog. 2010;2:3.
  • Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Annu Rev Med. 2011;62:381–396.
  • Rosenkranz MA, Davidson RJ. Affective neural circuitry and mind–body influences in asthma. Neuroimage. 2009;47:972–980.
  • Rosenkranz MA, Busse WW, Sheridan JF, et al. Are there neurophenotypes for asthma? Functional brain imaging of the interaction between emotion and inflammation in asthma. PLoS One. 2012;7:e40921.
  • Rosenkranz MA, Busse WW, Johnstone T, et al. Neural circuitry underlying the interaction between emotion and asthma symptom exacerbation. Proc Natl Acad Sci USA. 2005;102:13319–13324.
  • Buisman-Pijlman FTA, Gerrits MAFM, Van Ree JM. Increased opioid release in specific brain areas in animals exposed to prenatal morphine and emotional stress later in life. Neuroscience. 2009;159:405–413.
  • Kistemaker LEM, Gosens R. Acetylcholine beyond bronchoconstriction: roles in inflammation and remodeling. Trends Pharmacol Sci. 2015;36:164–171.
  • Ritz T, Kullowatz A, Goldman MD, et al. Airway response to emotional stimuli in asthma: the role of the cholinergic pathway. J Appl Physiol. 2010;108:1542–1549.
  • Hansen MB. The enteric nervous system I: organisation and classification. Toxicol Pharmacol. 2003;92:105–113.
  • Boeckxstaens G, Camilleri M, Sifrim D, et al. Fundamentals of neurogastroenterology: physiology/motility – sensation. Gastroenterology. 2016;150:1292–1304.e2.
  • Laitinen LA, Laitinen A. Innervation of airway smooth muscle. Am Rev Respir Dis. 1987;136:S38–S42.
  • Taché Y, Kiank C, Stengel A. A role for corticotropin-releasing factor in functional gastrointestinal disorders. Curr Gastroenterol Rep. 2009;11:270–277.
  • Tache Y, Martinez V, Wang L, et al. CRF1 receptor signaling pathways are involved in stress‐related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome. Br J Pharmacol. 2004;141:1321–1330.
  • Taché Y, Martinez V, Million M, et al. Stress-related alterations of gut motor function: role of brain corticotropin-releasing factor receptors. Am J Physiol Liver Physiol. 2001;280:G173–G177.
  • Söderholm JD, Yang P, Ceponis P, et al. Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology. 2002;123:1099–1108.
  • Taché Y, Perdue MH. Role of peripheral CRF signalling pathways in stress-related alterations of gut motility and mucosal function. Neurogastroenterol Motil. 2004;16(Suppl 1):137–142.
  • Theoharides TC, Enakuaa S, Sismanopoulos N, et al. Contribution of stress to asthma worsening through mast cell activation. Ann Allergy Asthma Immunol. 2012;109:14–19.
  • Kennedy Norton S, Barnstein B, Brenzovich J, et al. IL-10 suppresses mast cell IgE receptor expression and signaling in vitro and in vivo. J Immunol. 2008;180:2848–2854.
  • Oh SH, Park CO, Wu WH, et al. Corticotropin-releasing hormone downregulates IL-10 production by adaptive forkhead box protein 3–negative regulatory T cells in patients with atopic dermatitis. J Allergy Clin Immunol. 2012;129:151–159.e6.
  • Okuyama K, Dobashi K, Miyasaka T, et al. The involvement of glucocorticoids in psychological stress-induced exacerbations of experimental allergic asthma. Int Arch Allergy Immunol. 2014;163:297–306.
  • Chida Y, Sudo N, Sonoda J, et al. Early-life psychological stress exacerbates adult mouse asthma via the hypothalamus–pituitary–adrenal axis. Am J Respir Crit Care Med. 2007;175:316–322.
  • Wallaert B, Desreumaux P, Copin MC, et al. Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma. J Exp Med. 1995;182:1897–1904.
  • Pires GV, Souza HS, Elia C, et al. Small bowel of patients with asthma and allergic rhinitis: absence of inflammation despite the presence of major cellular components of allergic inflammation. Allergy Asthma Proc. 2004;25:253–259.
  • Wouters MM, Vicario M, Santos J. The role of mast cells in functional GI disorders. Gut. 2016;65:155–168.
  • Frieri M. Mast cell activation syndrome. Clin Rev Allergy Immunol. 2018;54:353–365.
  • Walker MM, Salehian SS, Murray CE, et al. Implications of eosinophilia in the normal duodenal biopsy - an association with allergy and functional dyspepsia. Aliment Pharmacol Ther. 2010;31:1229–1236.
  • Hall W, Buckley M, Crotty P, et al. Gastric mucosal mast cells are increased in Helicobacter pylori-negative functional dyspepsia. Clin Gastroenterol Hepatol. 2003;1:363–369.
  • Friesen CA, Lin Z, Singh M, et al. Antral inflammatory cells, gastric emptying, and electrogastrography in pediatric functional dyspepsia. Dig Dis Sci. 2008;53:2634–2640.
  • Feng B, La JH, Schwartz ES, et al. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012;302:G1085–98.
  • Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693–702.
  • Cremon C, Gargano L, Morselli-Labate AM, et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol. 2009;104:392.
  • Friesen CA, Andre L, Garola R, et al. Activated duodenal mucosal eosinophils in children with dyspepsia: a pilot transmission electron microscopic study. J Pediatr Gastroenterol Nutr. 2002;35:329–333.
  • Mukherjee AB, Zhang Z. Allergic asthma: influence of genetic and environmental factors. J Biol Chem. 2011;286:32883–32889.
  • Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol. 2015;16:45–56.
  • Kindt S, Van Oudenhove L, Broekaert D, et al. Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil. 2009;21:389–398.
  • Holgate ST. Innate and adaptive immune responses in asthma. Nat Med. 2012;18:673–683.
  • Pearson JS, Niven RM, Meng J, et al. Immunoglobulin E in irritable bowel syndrome: another target for treatment? A case report and literature review. Therap Adv Gastroenterol. 2015;8:270–277.
  • Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science. 2005;308:1635–1638.
  • Charlson ES, Bittinger K, Haas AR, et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med. 2011;184:957–963.
  • Korterink J, Devanarayana NM, Rajindrajith S, et al. Childhood functional abdominal pain: mechanisms and management. Nat Rev Gastroenterol Hepatol. 2015;12:159–171.
  • Ghoshal UC, Gwee KA, Post-infectious IBS. tropical sprue and small intestinal bacterial overgrowth: the missing link. Nat Rev Gastroenterol Hepatol. 2017;14:435–441.
  • Thabane M, Marshall JK. Post-infectious irritable bowel syndrome. World J Gastroenterol. 2009;15:3591–3596.
  • Barbara G, Cremon C, Pallotti F, et al. Postinfectious irritable bowel syndrome. J Pediatr Gastroenterol Nutr. 2009;48:S95–S97.
  • Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther. 2007;26:535–544.
  • Saulnier DM, Riehle K, Mistretta TA, et al. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology. 2011;141:1782–1791.
  • Igarashi M, Nakae H, Matsuoka T, et al. Alteration in the gastric microbiota and its restoration by probiotics in patients with functional dyspepsia. BMJ Open Gastroenterol. 2017;4:e000144.
  • Jadrešin O, Hojsak I, Mišak Z, et al. Lactobacillus reuteri DSM 17938 in the treatment of functional abdominal pain in children: RCT study. J Pediatr Gastroenterol Nutr. 2017;64:925–929.
  • De Palma G, Lynch MDJ, Lu J, et al. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Sci Transl Med. 2017;9:eaaf6397.
  • Roy CC, Kien CL, Bouthillier L, et al. Short-chain fatty acids: ready for prime time? Nutr Clin Pract. 2006;21:351–366.
  • Riba A, Olier M, Lacroix-Lamandé S, et al. Paneth cell defects induce microbiota dysbiosis in mice and promote visceral hypersensitivity. Gastroenterology. 2017;153:1594–1606.e2.
  • O’Mahony SM, Felice VD, Nally K, et al. Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats. Neuroscience. 2014;277:885–901.
  • Sun Y, Fihn BM, Sjövall H, et al. Enteric neurones modulate the colonic permeability response to luminal bile acids in rat colon in vivo. Gut. 2004;53:362–367.
  • Marri PR, Stern DA, Wright AL, et al. Asthma-associated differences in microbial composition of induced sputum. J Allergy Clin Immunol. 2013;131:346–52.e1–3.
  • Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways. PLoS One. 2010;5:e8578.
  • Kusel MMH, de Klerk NH, Kebadze T, et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol. 2007;119:1105–1110.
  • Ranucci G, Buccigrossi V, de Freitas MB, et al. Early-life Intestine microbiota and lung health in children. J Immunol Res. 2017;2017:1–5.
  • Arrieta MC, Stiemsma LT, Dimitriu PA, et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med. 2015;7:307ra152.
  • Penders J, Thijs C, van den Brandt PA, et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA birth Cohort study. Gut. 2007;56:661–667.
  • Sevelsted A, Stokholm J, Bisgaard H. Risk of asthma from cesarean delivery depends on membrane rupture. J Pediatr. 2016;171:38–42.e4.
  • Gdalevich M, Mimouni D, Mimouni M. Breast-feeding and the risk of bronchial asthma in childhood: A systematic review with meta-analysis of prospective studies. J Pediatr. 2001;139:261–266.
  • Wheeler ML, Limon JJ, Bar AS, et al. Immunological consequences of intestinal fungal dysbiosis. Cell Host Microbe. 2016;19:865–873.
  • Kim YG, Udayanga K, Totsuka N, et al. Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE₂. Cell Host Microbe. 2014;15:95–102.
  • Trompette A, Gollwitzer ES, Yadava K, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med. 2014;20:159–166.
  • Mettananda S, Yasara N, Fisher CA, et al. Synergistic silencing of α-globin and induction of γ-globin by histone deacetylase inhibitor, vorinostat as a potential therapy for β-thalassaemia. Sci Rep. 2019;9:1–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.